Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 04:03:20 +0200Mon, 15 Jul 2024 14:55:00 +0200Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 35, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dupixentHuman medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 35, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dupixentMon, 15 Jul 2024 14:55:00 +0200Human medicineDupixent : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-4390-par-en.pdfDupixent : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-4390-par-en.pdfWed, 11 Oct 2017 02:00:00 +0200Human medicine